Dr. Farley is the recipient of many awards for her service and achievements including: the Department of Medicines Nanette K. Wenger Distinguished Service Award; the Infectious Diseases Divisions Paul B. Beeson Faculty Recognition Award, the Southern Society for Clinical Investigations (SSCI) Founders Medal, and the R. Wayne Alexander Excellence in Research Accomplishment Award.
Dr. Farley is a Past-President of the American Federation for Medical Research and the Southern Society for Clinical Investigation, and a past member of the FDA Advisory committee on Vaccines and Related Biological Products. She serves as the Principal Investigator for the Georgia Emerging Infections Program (EIP), a CDC-funded surveillance network of epidemiologic and clinical research groups focused on invasive bacterial pathogens, influenza and foodborne diseases. The research program, in place in Atlanta since 1988 and currently covering the entire Metropolitan Atlanta area, has been highly productive, providing population-based assessment of the epidemiology and risk factors for a number of important bacterial infections, including pneumococcal disease, group B Streptococcus, Clostridium difficile, and community-associated MRSA disease. Other EIP projects include post-licensure vaccine effectiveness studies. She has also studied molecular mechanisms of H. influenzae pathogenesis in her laboratory. Dr. Farley has been inducted into the Emory University School of Medicine Millipub Club, an honor reserved for authors of published articles that are cited 1000 times in the literature.